MODIFIED LATEX AGGLUTINATION-TEST FOR ANTIBODIES TO TOXOPLASMA-GONDII IN ELUATES FROM GUTHRIE CARDS

被引:13
作者
PARKER, SP [1 ]
CUBITT, WD [1 ]
机构
[1] INST CHILD HLTH,DEPT VIROL,30 GUILFORD ST,LONDON WC1N 1EH,ENGLAND
关键词
D O I
10.1136/jcp.45.10.907
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aims: To determine whether the Eiken particle agglutination test could be modified to make it sufficiently sensitive to screen blood samples collected on Guthrie cards for the presence of antibodies to Toxoplasma gondii; to evaluate the specificity of the modified system; and to compare seroepidemiological data on the prevalence of T gondii in pregnant women. Methods: Simulated dried blood spots were prepared from sera from pregnant women booking for antenatal care. Eluates from the simulated dried blood spot cards and sera were tested in parallel using the modified test (1 in 5 dilution of latex) and the standard assay (neat latex particles) and endpoints determined. Guthrie card eluates, from neonates in three Thames regions, were then tested using the modified test. Results: The modified test produced a 4-21-fold increase in antibody titre in 85 sera when tested in parallel with the standard test. Eluates of 1681170 from simulated dried blood spots derived from seropositive patients gave a positive result in the modified test. The two eluates which gave a negative result were derived from patients with an equivocal titre of 1116 in the standard serum test. Of the eluates derived from serum negative patients all 103 were negative at a dilution of 1 in 4 in the modified test. The seroprevalence of antibodies to T gondii in pregnancy was 21.8% using the standard test. A similar value of 20.5% was obtained when dried blood spots from neonates in a similar region of London were tested by the modified test. Conclusions: The modified Eiken Toxoreagent test is sensitive, simple, and economic for screening large numbers of dried blood spots. The procedure could be easily semiautomated and the technique applied to the mass screening of neonatal blood samples collected on Guthrie cards to determine the seroprevalence of T gondii in pregnant women.
引用
收藏
页码:907 / 909
页数:3
相关论文
共 23 条
[1]   PREVALENCE OF ANTIBODIES TO HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2 IN PREGNANT-WOMEN, AND ESTIMATED RATES OF INFECTION [J].
ADES, AE ;
PECKHAM, CS ;
DALE, GE ;
BEST, JM ;
JEANSSON, S .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 1989, 43 (01) :53-60
[2]   PREVALENCE OF MATERNAL HIV-1 INFECTION IN THAMES REGIONS - RESULTS FROM ANONYMOUS UNLINKED NEONATAL TESTING [J].
ADES, AE ;
PARKER, S ;
BERRY, T ;
HOLLAND, FJ ;
DAVISON, CF ;
CUBITT, D ;
HJELM, M ;
WILCOX, AH ;
HUDSON, CN ;
BRIGGS, M ;
TEDDER, RS ;
PECKHAM, CS .
LANCET, 1991, 337 (8757) :1562-1565
[3]   COMPARATIVE-STUDY OF 3 TESTS (DYE TEST, INDIRECT HEMAGGLUTINATION TEST, LATEX AGGLUTINATION-TEST) FOR THE DETECTION OF ANTIBODIES TO TOXOPLASMA-GONDII IN HUMAN-SERA [J].
BALFOUR, AH ;
FLECK, DG ;
HUGHES, HP ;
SHARP, D .
JOURNAL OF CLINICAL PATHOLOGY, 1982, 35 (02) :228-232
[4]  
BARBARA JAJ, 1989, MED LAB SCI, V46, P135
[5]   EVALUATION OF 5 COMMERCIAL ASSAYS FOR SCREENING ANTENATAL SERA FOR ANTIBODIES TO TOXOPLASMA-GONDII [J].
CUBITT, WD ;
ADES, AE ;
PECKHAM, CS .
JOURNAL OF CLINICAL PATHOLOGY, 1992, 45 (05) :435-438
[6]  
DESMONTS G, 1974, B NEW YORK ACAD MED, V50, P146
[7]   DIAGNOSIS OF TOXOPLASMOSIS [J].
FLECK, DG .
JOURNAL OF CLINICAL PATHOLOGY, 1989, 42 (02) :191-193
[8]   TOXOPLASMA-GONDII ANTIBODIES IN PREGNANT-WOMEN IN STOCKHOLM IN 1969, 1979, AND 1987 [J].
FORSGREN, M ;
GILLE, E ;
LJUNGSTROM, I ;
NOKES, DJ .
LANCET, 1991, 337 (8754) :1413-1414
[9]   CONGENITAL TOXOPLASMOSIS - A PROSPECTIVE SURVEY IN BRUSSELS [J].
FOULON, W ;
NAESSENS, A ;
VOLCKAERT, M ;
LAUWERS, S ;
AMY, JJ .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1984, 91 (05) :419-423
[10]   SEROPREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS AMONG CHILDBEARING WOMEN - ESTIMATION BY TESTING SAMPLES OF BLOOD FROM NEWBORNS [J].
HOFF, R ;
BERARDI, VP ;
WEIBLEN, BJ ;
MAHONEYTROUT, L ;
MITCHELL, ML ;
GRADY, GF .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (09) :525-530